Amgen, 3.875% 15nov2021, USD (US031162BM10)

Download

Copy issue information to clipboard

Copy to clipboard

Data copied to the clipboard

PDF download

Choose all Reset all

Download Cancel

International bonds, Senior Unsecured

Status

Early redeemed

Amount

1,750,000,000 USD

Placement

***

Early redemption

*** (-)

ACI on

Country of risk

USA

Current coupon

Price

Yield / Duration

Calculate in two clicks! yield, duration and other parameters

Calculator What is a calculator?

Placement amount

1,750,000,000 USD
Minimum Settlement Amount

2,000 USD
ISIN

US031162BM10
CFI

DBFUGR
FIGI

BBG0027SXCV9
SEDOL

B4PTZS2
Ticker

AMGN 3.875 11/15/21

explore the most comprehensive database

900 000

bonds globally

Over 400

pricing sources

80 000

stocks

116 000

ETF & Funds

track your portfolio in the most efficient way

Bond Search
Watchlist
Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Trading chart

Stock exchange selection

More about Cbonds Estimation

Bond is not traded; the issue is redeemed

Data display in a chart | table

Work with the chart: switching the price, period, issue comparison

Customize fields in the table

Found:

Show all fields

from

ADD-IN
Cbonds add-in API
bond data api

Authorization required

You need to request access

* Data is not available within the selected subscription

Issue information

Profile

Amgen Inc. is an American multinational biopharmaceutical company headquartered in California. Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel ...

Show more Hide

Research report by Cbonds-PRAAMS

Save

Authorization required

Report download is available only paid Premium subscription access

Borrower

Go to the issuer page
Amgen
Full borrower / issuer name

Amgen
Sector

Corporate
Industry

Pharmaceutical Preparation and Biotechnology
Stocks

Amgen, ordinary share
Amgen, Brazilian depositary receipt (GDR)
Amgen, Canadian depositary receipt (CDR)
Amgen, depositary receipt

Volume

Placement amount

1,750,000,000 USD

Face value

Minimum Settlement Amount

2,000 USD
Outstanding face value

*** USD
Increment

*** USD
Face value

1,000 USD

Cash flow parameters

Reference rate

***

Coupon Rate

***

Day count convention

***

Interest Accrual Date

***

Coupon frequency

*** time(s) per year
Payment currency

***
Maturity date

***
Early redemption date

***

Cash flow

Calculations for international bonds are made according to the minimum trading lot

Export to Excel

Early redemption terms

***

explore the most comprehensive database

900 000

bonds globally

Over 400

pricing sources

80 000

stocks

116 000

ETF & Funds

track your portfolio in the most efficient way

Bond Search
Watchlist
Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Placement

Placement method

Open subscription
Placement type

Public
Placement format

Book building
Placement

***
Initial issue price (yield)

(***%)
Geographic breakdown

***
Investor breakdown

***

Participants

Bookrunner

***, ***, ***
Depository

***, ***, ***

Conversion and exchange

Conversion terms

***

Latest issues

Show all

Similar issues

News

10/07/2025	1 Top Dividend Growth Stock to Buy Right Now
09/07/2025	Merck Faces Multiple Challenges: Will It Steer Through Successfully?
04/07/2025	Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity
03/07/2025	Better Dividend ETF to Buy for Passive Income: SCHD or GCOW
02/07/2025	This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk

All organization news

IFRS/US GAAP reports

2025
	I q eng



2024
	I q eng
	II q eng

	IV q eng
2023
	I q eng
	II q eng
	III q eng
	IV q eng
2022
	I q eng
	II q eng
	III q eng
	IV q eng
2021
	I q eng
	II q eng
	III q eng
	IV q eng
2020
	I q eng
	II q eng
	III q eng
	IV q eng
2019
	I q eng
	II q eng
	III q eng
	IV q eng
2018
	I q eng
	II q eng
	III q eng
	IV q eng
2017
	I q eng
	II q eng
	III q eng
	IV q eng
2016
	I q eng
	II q eng
	III q eng
	IV q eng
2015
	I q eng
	II q eng
	III q eng
	IV q eng
2014



	IV q eng

Show all Hide

Authorization required

You need to request access

Identifiers

ISIN

***
Cbonds ID

52931
CUSIP

***
CUSIP 144A

***
CFI

DBFUGR
FIGI

BBG0027SXCV9
WKN

A1GW8T
SEDOL

B4PTZS2
Ticker

AMGN 3.875 11/15/21
Type of security by CBR

***

Ratings

Bond classification

Senior Unsecured
Registered
Coupon bonds
Amortization
Callable
CDO
Convertible
Dual currency bonds
Variable rate
For qualified investors (CIS region)
Foreign bonds
Green bonds
Guaranteed
Inflation-linked principal
Supranational bond issues
Inflation-linked coupon
Mortgage bonds
Non-complex financial instruments (MiFID)
Perpetual
Payment-in-kind
Non-Marketable Securities
Redemption Linked
Restructuring
Retail bonds
Covered
Securitization
Structured product
Commercial Bonds
Subordinated
Sukuk
Trace-eligible

Show more Hide

Restructuring

***